Manufacturers Life Insurance Company, The Collegium Pharmaceutical, Inc Transaction History
Manufacturers Life Insurance Company, The
- $103 Billion
- Q1 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 15,768 shares of COLL stock, worth $507,414. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,768
Previous 13,406
17.62%
Holding current value
$507,414
Previous $412,000
48.54%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding COLL
# of Institutions
231Shares Held
39.5MCall Options Held
104KPut Options Held
15.4K-
Black Rock Inc. New York, NY5.87MShares$189 Million0.01% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$84.8 Million1.65% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$83.2 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.33MShares$75 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY1.83MShares$59 Million2.43% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.1B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...